<VariationArchive VariationID="419391" VariationName="NM_000548.5(TSC2):c.5214del (p.Lys1739fs)" VariationType="Deletion" Accession="VCV000419391" Version="4" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-02-20" DateCreated="2017-04-27" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="409499" VariationID="419391">
      <GeneList>
        <Gene Symbol="TSC2" FullName="TSC complex subunit 2" GeneID="7249" HGNC_ID="HGNC:12363" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>16p13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="2047985" stop="2089491" display_start="2047985" display_stop="2089491" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="2097989" stop="2138712" display_start="2097989" display_stop="2138712" Strand="+" />
          </Location>
          <OMIM>191092</OMIM>
          <Haploinsufficiency last_evaluated="2020-06-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=TSC2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-06-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=TSC2">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_000548.5(TSC2):c.5214del (p.Lys1739fs)</Name>
      <CanonicalSPDI>NC_000016.10:2088278:CC:C</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>16p13.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="2088279" stop="2088279" display_start="2088279" display_stop="2088279" variantLength="1" positionVCF="2088278" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="2138280" stop="2138280" display_start="2138280" display_stop="2138280" variantLength="1" positionVCF="2138279" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>K1636fs</ProteinChange>
      <ProteinChange>K1692fs</ProteinChange>
      <ProteinChange>K1696fs</ProteinChange>
      <ProteinChange>K1739fs</ProteinChange>
      <ProteinChange>K1624fs</ProteinChange>
      <ProteinChange>K1673fs</ProteinChange>
      <ProteinChange>K1672fs</ProteinChange>
      <ProteinChange>K1683fs</ProteinChange>
      <ProteinChange>K1716fs</ProteinChange>
      <ProteinChange>K1495fs</ProteinChange>
      <ProteinChange>K1695fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000548.5" sequenceAccession="NM_000548" sequenceVersion="5" change="c.5214del" MANESelect="true">
            <Expression>NM_000548.5:c.5214del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000539.2" sequenceAccession="NP_000539" sequenceVersion="2" change="p.Lys1739fs">
            <Expression>NP_000539.2:p.Lys1739fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.2088280del" Assembly="GRCh38">
            <Expression>NC_000016.10:g.2088280del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.2138281del" Assembly="GRCh37">
            <Expression>NC_000016.9:g.2138281del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_005895.1" sequenceAccession="NG_005895" sequenceVersion="1" change="g.43975del">
            <Expression>NG_005895.1:g.43975del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008617.1" sequenceAccession="NG_008617" sequenceVersion="1" change="g.54942del">
            <Expression>NG_008617.1:g.54942del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001077183.3" sequenceAccession="NM_001077183" sequenceVersion="3" change="c.5013del">
            <Expression>NM_001077183.3:c.5013del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001070651.1" sequenceAccession="NP_001070651" sequenceVersion="1" change="p.Lys1672fs">
            <Expression>NP_001070651.1:p.Lys1672fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001114382.3" sequenceAccession="NM_001114382" sequenceVersion="3" change="c.5145del">
            <Expression>NM_001114382.3:c.5145del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001107854.1" sequenceAccession="NP_001107854" sequenceVersion="1" change="p.Lys1716fs">
            <Expression>NP_001107854.1:p.Lys1716fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001318827.2" sequenceAccession="NM_001318827" sequenceVersion="2" change="c.4905del">
            <Expression>NM_001318827.2:c.4905del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001305756.1" sequenceAccession="NP_001305756" sequenceVersion="1" change="p.Lys1636fs">
            <Expression>NP_001305756.1:p.Lys1636fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001318829.2" sequenceAccession="NM_001318829" sequenceVersion="2" change="c.4869del">
            <Expression>NM_001318829.2:c.4869del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001305758.1" sequenceAccession="NP_001305758" sequenceVersion="1" change="p.Lys1624fs">
            <Expression>NP_001305758.1:p.Lys1624fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001318831.2" sequenceAccession="NM_001318831" sequenceVersion="2" change="c.4482del">
            <Expression>NM_001318831.2:c.4482del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001305760.1" sequenceAccession="NP_001305760" sequenceVersion="1" change="p.Lys1495fs">
            <Expression>NP_001305760.1:p.Lys1495fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001318832.2" sequenceAccession="NM_001318832" sequenceVersion="2" change="c.5046del">
            <Expression>NM_001318832.2:c.5046del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001305761.1" sequenceAccession="NP_001305761" sequenceVersion="1" change="p.Lys1683fs">
            <Expression>NP_001305761.1:p.Lys1683fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001363528.2" sequenceAccession="NM_001363528" sequenceVersion="2" change="c.5016del">
            <Expression>NM_001363528.2:c.5016del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001350457.1" sequenceAccession="NP_001350457" sequenceVersion="1" change="p.Lys1673fs">
            <Expression>NP_001350457.1:p.Lys1673fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001370404.1" sequenceAccession="NM_001370404" sequenceVersion="1" change="c.5082del">
            <Expression>NM_001370404.1:c.5082del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001357333.1" sequenceAccession="NP_001357333" sequenceVersion="1" change="p.Lys1695fs">
            <Expression>NP_001357333.1:p.Lys1695fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001370405.1" sequenceAccession="NM_001370405" sequenceVersion="1" change="c.5073del">
            <Expression>NM_001370405.1:c.5073del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001357334.1" sequenceAccession="NP_001357334" sequenceVersion="1" change="p.Lys1692fs">
            <Expression>NP_001357334.1:p.Lys1692fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_021055.3" sequenceAccession="NM_021055" sequenceVersion="3" change="c.5085del">
            <Expression>NM_021055.3:c.5085del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_066399.2" sequenceAccession="NP_066399" sequenceVersion="2" change="p.Lys1696fs">
            <Expression>NP_066399.2:p.Lys1696fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_487t1" sequenceAccession="LRG_487t1">
            <Expression>LRG_487t1:c.5214del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_487" sequenceAccession="LRG_487">
            <Expression>LRG_487:g.43975del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA16620105" DB="ClinGen" />
        <XRef Type="rs" ID="397515139" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000548.5(TSC2):c.5214del (p.Lys1739fs) AND not provided" Accession="RCV000486348" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2015-07-13" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000548.5(TSC2):c.5214del (p.Lys1739fs) AND Tuberous sclerosis 2" Accession="RCV002525795" Version="2">
        <ClassifiedConditionList TraitSetID="3366">
          <ClassifiedCondition DB="MedGen" ID="C1860707">Tuberous sclerosis 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-06-12" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-06-12" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2017-04-27" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10732801</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16114042</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18854862</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20165957</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21309039</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3366" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6897" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Tuberous sclerosis 2</ElementValue>
                <XRef ID="Tuberous+sclerosis%2C+type+2/7257" DB="Genetic Alliance" />
                <XRef ID="MONDO:0013199" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">TSC2</ElementValue>
                <XRef Type="MIM" ID="613254" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15640" />
                <XRef ID="15640" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5381" />
                <XRef ID="5381" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Tuberous sclerosis complex (TSC) involves abnormalities of the skin (hypomelanotic macules, confetti skin lesions, facial angiofibromas, shagreen patches, fibrous cephalic plaques, ungual fibromas); brain (subependymal nodules, cortical tubers, and subependymal giant cell astrocytomas [SEGAs], seizures, intellectual disability / developmental delay, psychiatric illness); kidney (angiomyolipomas, cysts, renal cell carcinomas); heart (rhabdomyomas, arrhythmias); and lungs (lymphangioleiomyomatosis [LAM], multifocal micronodular pneumonocyte hyperplasia). Central nervous system tumors are the leading cause of morbidity and mortality; renal disease is the second leading cause of early death.</Attribute>
                <XRef ID="NBK1220" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301399</ID>
                <ID Source="BookShelf">NBK1220</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="Orphanet, 2007">
                <URL>https://www.orpha.net/data/patho/Pro/en/Emergency_TuberousSclerosis.pdf</URL>
                <CitationText>Orphanet, Tuberous sclerosis, 2007</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23519317</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <XRef ID="805" DB="Orphanet" />
              <XRef ID="C1860707" DB="MedGen" />
              <XRef ID="MONDO:0013199" DB="MONDO" />
              <XRef Type="MIM" ID="613254" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1102265" SubmissionDate="2019-01-29" DateLastUpdated="2017-04-27" DateCreated="2017-04-27">
        <ClinVarSubmissionID localKey="GDX:471996|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000567158" DateUpdated="2017-04-27" DateCreated="2017-04-27" Type="SCV" Version="4" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2015-07-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.5214delC deletion in the TSC2 gene causes a frameshift starting with codon Lysine 1739, changesthis amino acid to a Serine residue and creates a premature Stop codon at position 87 of the new readingframe, denoted p.Lys1739SerfsX87. It was not observed in approximately 6,500 individuals of Europeanand African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a commonbenign variant in these populations. This variant is predicted to cause loss of normal protein function asthe last 69 amino acids of the protein are replaced by 86 aberrant residues. Although this variant has notbeen previously reported to our knowledge, we interpret it as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TSC2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000548.3:c.5214delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5897698" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="16854732|MedGen:C1860707" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003205871" DateUpdated="2024-02-20" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-06-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10732801</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16114042</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18854862</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20165957</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21309039</ID>
          </Citation>
          <Comment>This sequence change results in a frameshift in the TSC2 gene (p.Lys1739Serfs*87). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 69 amino acid(s) of the TSC2 protein and extend the protein by 17 additional amino acid residues. For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the TSC2 protein in which other variant(s) (p.Arg1743Gln) have been determined to be pathogenic (PMID: 10732801, 16114042, 18854862, 20165957, 21309039). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. ClinVar contains an entry for this variant (Variation ID: 419391). This variant has not been reported in the literature in individuals affected with TSC2-related conditions. This variant is not present in population databases (gnomAD no frequency).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TSC2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000016.9:g.2138280del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1860707" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5897698" TraitType="Disease" MappingType="XRef" MappingValue="C1860707" MappingRef="MedGen">
        <MedGen CUI="C1860707" Name="Tuberous sclerosis 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1102265" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

